Organon Pharma Indonesia Tbk. vs Lovina Beach Brewery Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Lovina Beach Brewery Tbk. trades at Rp62 (market cap 675.48B, 3.92M 24h volume). The key difference: Lovina Beach Brewery Tbk. is far larger — about 6.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | STRK | |
|---|---|---|
Market Cap | 104.4B | 675.48B |
Volume | — | 3.92M |
Lot | — | 39.18K |
Turnover | — | 242.11M |
Average Price | — | 61.8 |
Value | — | 242.11M |
Indicative Equilibrium Price | — | 62 |
Indicative Equilibrium Volume | — | 749 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Lovina Beach Brewery Tbk (the Company) was established based on the Notarial Deed of Notary of J.S Wibisono, S.H., in Denpasar, No. 42 dated October 19, 2010. The Company commenced its commercial operations in 2010
Read more on STRK →